Silicon is one of the most abundant trace elements in the human body, and its concentration in blood is similar to that of other elements essential for life (iron, copper, and zinc). It is found in tissues such as:
For nutraceutical development, understanding how silicon is absorbed, distributed, and utilized is critical to selecting effective ingredient systems.
Dietary silicon is found in sources such as:
However, naturally occurring silicon is often present in forms with limited bioavailability, which can restrict its functional contribution.
Silicon can exist in multiple chemical forms, each with different characteristics:
Highly polymerized forms (e.g., silica, silicates) tend to be poorly absorbed, while stabilized, low-molecular-weight forms are more suitable for nutraceutical applications.
MMST (CH₃Si(OH)₃) is a stabilized derivative of Orthosilicic acid (OSA), designed to improve:
Its molecular structure supports its use in formulations requiring consistent absorption and stability. (See post: LIVING SILICA’s Innovation: Unlocking Bioavailability for Better Results)
The behavior of silicon in the body can be described using the pharmacokinetic framework of Absorption, Distribution, Metabolism, and Excretion (ADME).
Following oral intake, bioavailable silicon forms:
Low molecular weight and solubility are key factors influencing this process.
After absorption:
This systemic availability enables interaction with structurally relevant tissues.
Silicon is associated with tissues involved in structural and connective functions, including:
It is linked to biological processes such as:
Silicon homeostasis is regulated by the body:
This contributes to its generally favorable safety profile when used appropriately.
From a product development perspective, the effectiveness of silicon depends on its ability to remain:
Ingredients that aggregate or polymerize during storage or digestion may show reduced functionality.
Silicium Laboratories develops silicon ingredients designed to optimize performance in finished products.
The LIVING SILICA® portfolio includes:
(See post: Living Silica Ingredients for Bulk Supply and Private Label Development)
These systems are developed to support:
Bioavailable silicon ingredients can be incorporated into formulations targeting:
Their effectiveness depends on delivering silicon in a stable and bioavailable form.
As the nutraceutical industry evolves, there is increasing emphasis on ingredient functionality, bioavailability, and scientific validation.
Understanding the absorption and behavior of silicon enables more informed decisions in ingredient selection and product design.
For specifications, scientific documentation, or formulation guidance:
Or fill out our contact form to connect with our team: